NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, is pleased to announce...

Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, today announced Octavio Marquez, president and chief executive officer, and Tom Timko, executive vice...

Module brings world's first ultrasonic touch on metal slider interface to the steering wheel replacing plastic scroller wheels. RADOLFZELL, Germany, Nov. 21, 2024 /PRNewswire/ -- BCS Automotive...

Big Sean and Chips Ahoy! bring bold flavor, style, and an 18-foot cookie installation to ComplexCon, merging food and culture like never before NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Chips Ahoy!...

Simple, fast, reliable detection of non-small cell lung cancer biomarkers from tissue or blood New data to be presented at ISLB 2024 demonstrates best-in-class liquid biopsy clinical performance...

Front lighting module 'Nexlide A+' wins CES 2025 Innovation Award Industry's first application of surface light source technology to front lighting module, making it 40% slimmer and increasing...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition...

Presentation at the American Epilepsy Society Annual Meeting will also highlight proposed design of planned Phase 3 study of radiprodil in children with gain-of-function variants NEW YORK, Nov....

SKY-1214 demonstrates impressive synergistic anti-cancer activity in vivo and in vitro in combination with multiple commonly used and emerging agents for the treatment of relapsed/refractory...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Healthcare Conference on December 5, 2024,...